Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int Endod J ; 53(7): 974-985, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32159857

RESUMEN

AIM: To introduce a new method to select anatomically matched teeth using micro-computed tomographic (micro-CT) technology. METHODOLOGY: Single-rooted mandibular incisors with a single root canal (n = 60) were selected and distributed into three experimental groups according to the method used for matching 10 pairs of teeth in each group. In group 1, the pairs of mandibular incisors were randomly selected from a pool of teeth. In group 2, teeth were paired based on the measurement of canal width 5 mm from the root apex using radiographs taken from buccolingual and mesiodistal directions. In group 3, teeth were scanned (pixel size of 14.25 µm) and pair-matched based on the anatomical aspects of the root canal, named aspect ratio (AR), volume and three-dimensional canal geometry. After allocating the specimens into groups 1 and 2, the teeth were scanned and the canal morphology evaluated as in group 3. A bivariate Pearson's regression analysis was performed correlating the individual AR values of each pair, and the correlation coefficient was used to estimate the strength of the pair-matching process. One-way anova post hoc Tukey's tests were applied for pairwise comparisons at a significance level of 5%. RESULTS: The micro-CT revealed that 100% of the samples had strong (80%) or very strong (20%) correlations with respect to AR values. Analysis of the radiographic method revealed strong correlation in two pairs (20%), but most of the samples had weak (30%) or negligible (30%) correlation coefficients. The randomization method resulted in three pairs (30%) with very strong correlations, whilst 50% had weak or negligible rates. A significant difference in correlation coefficients was observed in the micro-CT method compared to the other groups (P < 0.05), whilst no difference was detected between radiographic and randomized methods (P > 0.05). Eta-squared (η2 ) calculations demonstrated a very high effect size in the micro-CT group for selecting pairs (0.99) and lower effect sizes in the radiographic (0.67) and randomized (0.66) groups. CONCLUSIONS: Use of Micro-CT was able to provide better control of the confounding effect that anatomical variances in tooth morphology may have on the results in experiments with matched-pair design.


Asunto(s)
Cavidad Pulpar , Tratamiento del Conducto Radicular , Diente Premolar , Incisivo , Microtomografía por Rayos X
2.
J Obes ; 2013: 245683, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23984050

RESUMEN

BACKGROUND: An active device that downregulates abdominal vagal signalling has resulted in significant weight loss in feasibility studies. OBJECTIVE: To prospectively evaluate the effect of intermittent vagal blocking (VBLOC) on weight loss, glycemic control, and blood pressure (BP) in obese subjects with DM2. METHODS: Twenty-eight subjects were implanted with a VBLOC device (Maestro Rechargeable System) at 5 centers in an open-label study. Effects on weight loss, HbA1c, fasting blood glucose, and BP were evaluated at 1 week to 12 months. RESULTS: 26 subjects (17 females/9 males, 51 ± 2 years, BMI 37 ± 1 kg/m(2), mean ± SEM) completed 12 months followup. One serious adverse event (pain at implant site) was easily resolved. At 1 week and 12 months, mean excess weight loss percentages (% EWL) were 9 ± 1% and 25 ± 4% (P < 0.0001), and HbA1c declined by 0.3 ± 0.1% and 1.0 ± 0.2% (P = 0.02, baseline 7.8 ± 0.2%). In DM2 subjects with elevated BP (n = 15), mean arterial pressure reduced by 7 ± 3 mmHg and 8 ± 3 mmHg (P = 0.04, baseline 100 ± 2 mmHg) at 1 week and 12 months. All subjects MAP decreased by 3 ± 2 mmHg (baseline 95 ± 2 mmHg) at 12 months. CONCLUSIONS: VBLOC was safe in obese DM2 subjects and associated with meaningful weight loss, early and sustained improvements in HbA1c, and reductions in BP in hypertensive DM2 subjects. This trial is registered with ClinicalTrials.gov NCT00555958.


Asunto(s)
Glucemia/metabolismo , Presión Sanguínea , Diabetes Mellitus Tipo 2/terapia , Hipertensión/terapia , Obesidad/terapia , Vagotomía , Nervio Vago/fisiopatología , Australia , Biomarcadores/sangre , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/fisiopatología , Femenino , Hemoglobina Glucada/metabolismo , Humanos , Hipertensión/sangre , Hipertensión/complicaciones , Hipertensión/fisiopatología , Masculino , México , Persona de Mediana Edad , Noruega , Obesidad/sangre , Obesidad/complicaciones , Obesidad/fisiopatología , Estudios Prospectivos , Resultado del Tratamiento , Vagotomía/instrumentación , Pérdida de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA